Transcription of CTN-0030 Protocol Book
{{id}} {{{paragraph}}}
Example: biology
CTN-0030 Protocol Book
NIDA-CTN-0030A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic DependenceNATIONAL INSTITUTE ON DRUG ABUSECLINICAL TRIALS NETWORKP rotocol ( 2007)CONTACT INFORMATION FOR INVESTIGATORS/COLLABORATORST itleNameAffiliationLead Investigator for Protocol Implementation(LI)Roger Weiss, New England NodeLead Investigator for Protocol DevelopmentWalter Ling, NodeProject DirectorJennifer Sharpe Potter, , MPHN orthern New England NodeProject Co-DirectorAl Hasson, Pacific NodeProject ManagerKristi Prather, New England NodeMedical MonitorHilary Connery, , New England NodeSafety MonitorRobert Lindblad, Coordinating CenterBiostatisticiansEva Petkova, Island NodeJanet Levy, CCTNR egulatory SpecialistScott Provost, , New England NodeTraining DirectorMarc Copersino, New England NodeNIDA LiaisonsJack Blaine, CCTNP etra Jacobs, CCTNE xecutive CommitteeFranklin Ingram, Carolina Node Carmen Masson, NodeMichael Bogenschutz, NodeJeff Selzer, Island
Table of Contents CTN-0030 Protocol page iv Version 3.4 11.1 Overview of Study Design .....11-1
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: